back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-24 18:48 Tx date 2024-05-23 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$219,760
+67,000 vol $3.28 each |
323,000 | |
| Filed 2023-05-26 17:28 Tx date 2023-05-24 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$140,800
+55,000 vol $2.56 each |
256,000 | |
| Filed 2022-05-26 22:02 Tx date 2022-05-25 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,250
+41,000 vol $2.25 each |
201,000 | |
| Filed 2021-06-07 20:20 Tx date 2021-06-03 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,900
+22,000 vol $2.95 each |
160,000 | |
| Filed 2020-06-01 17:31 Tx date 2020-05-28 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,520
+22,000 vol $2.16 each |
138,000 | |
| Filed 2019-08-20 16:28 Tx date 2019-08-17 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+22,000 vol $1.50 each |
116,000 | |
| Filed 2018-06-22 Tx date 2018-06-19 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$148,500
+22,000 vol $6.75 each |
94,000 | |
| Filed 2017-06-22 Tx date 2017-06-21 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,100
+22,000 vol $3.55 each |
72,000 | |
| Filed 2017-03-28 Tx date 2017-03-24 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,500
+50,000 vol $3.15 each |
50,000 | |
| Filed 2017-03-28 Tx date 2017-03-23 |
$ABUS
Arbutus Biopharma Corporation |
Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|